CW
MLYS icon

CreativeOne Wealth’s Mineralys Therapeutics MLYS Stock Holding History

CreativeOne Wealth’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$291K Hold
10,750
– – 0.01% 988
2025
Q4 		$390K Hold
10,750
– – 0.01% 866
2025
Q3 		$408K Hold
10,750
– – 0.01% 839
2025
Q2 		$145K Hold
10,750
– – ﹤0.01% 1082
2025
Q1 		$171K Hold
10,750
– – 0.01% 1012
2024
Q4 		$132K Hold
10,750
– – ﹤0.01% 1034
2024
Q3 		$130K Hold
10,750
– – ﹤0.01% 923
2024
Q2 		$126K Hold
10,750
– – 0.01% 747
2024
Q1 		$139K Hold
10,750
– – 0.01% 855
2023
Q4 		$92K Buy
+10,750
New +$84.4K 0.01% 611

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

CreativeOne Wealth's MLYS Position: Q1 2026 in Review

CreativeOne Wealth held its Mineralys Therapeutics (MLYS) position steady in Q1 2026 at 10,750 shares worth $291K. The position accounts for 0.01% of the portfolio, ranked #988.

CreativeOne Wealth first reported a position in MLYS in Q4 2023 and has held it in 10 quarters since. The position peaked at $408K in Q3 2025. 214 funds tracked by Wall St. Rank hold MLYS as of Q1 2026.

  • CreativeOne Wealth held 10,750 shares of Mineralys Therapeutics worth $291K as of Q1 2026.
  • CreativeOne Wealth left its Mineralys Therapeutics share count unchanged in Q1 2026.
  • Mineralys Therapeutics made up 0.01% of CreativeOne Wealth's portfolio in Q1 2026, its #988 holding.
  • CreativeOne Wealth first reported a position in Mineralys Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • CreativeOne Wealth's Mineralys Therapeutics position peaked at $408K in Q3 2025.
  • 214 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.